By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Nordic Nanovector 

Kjelsåsveien 168 B

  Oslo  0884  Norway
Phone: 47-22-18-33-01 Fax: 47-22-58-00-07


Company News
Nordic Nanovector - Financial Calendar 3/27/2017 9:49:45 AM
Nordic Nanovector Publishes Annual Report 2016 3/24/2017 10:41:48 AM
Nordic Nanovector Announces First Patient Dosed In Phase I Study Of Betalutin In Diffuse Large B-Cell Lymphoma (DLBCL), An Aggressive Form Of NHL 3/17/2017 6:30:58 AM
Nordic Nanovector - Results For Fourth Quarter And Full Year 2016 2/28/2017 8:21:55 AM
Nordic Nanovector: Invitation To Fourth Quarter And Full Year 2016 Results Presentation And Webcast 2/22/2017 7:40:52 AM
Nordic Nanovector: Share Capital Increase Registered 2/2/2017 10:46:40 AM
Nordic Nanovector: Share Options Granted, Including Options To Primary Insiders 2/2/2017 10:25:21 AM
Nordic Nanovector: Mandatory Notification Of Trade - Primary Insiders 12/9/2016 11:09:23 AM
Nordic Nanovector: Betalutin In Combination With Rituximab Demonstrates Synergistic Anti-Tumour Effect In Preclinical Non-Hodgkin Lymphoma Model 12/6/2016 9:42:59 AM
Nordic Nanovector: Single-Dose Betalutin Shows Promising Efficacy, Improved Duration Of Response And Favourable Safety In Relapsed NHL Patients 12/5/2016 9:59:28 AM